Your Article Summary
See Latest ArticlesThe use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS
Journal of Affective Disorders, 06/22/09
Kelly T et al. - A high percentage of bipolar II and bipolar NOS patients with treatment resistant depression improved on T3. Despite the use of higher than usual doses in many of the patients, the medication was well tolerated. Augmentation with supraphysiologic doses of T3 should be considered in cases of treatment resistant bipolar depression.
Methods- Retrospective chart review of patients treated in a private clinic between 2002 and 2006.
- The charts of 125 patients with bipolar II disorder and 34 patients with bipolar disorder NOS were reviewed.
- Patients had been unsuccessfully treated with an average of 14 other medications before starting T3.
- At an average dose of 90.4 mcg (range 13 mcg–188 mcg) the medication was well tolerated.
- None of the patients experienced a switch into hypomania, and only 16 discontinued due to side effects.
- Improvement was experienced by 84%, and 33% experienced full remission.
Related Articles
Safety and Efficacy of Quetiapine in Bipolar Depression
Annals of Pharmacotherapy, 10/13/09
Relevance Score: 67%
Mecamylamine ? a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Expert Opinion in Pharmacotherapy, 11/02/09
Relevance Score: 64%
Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09
Relevance Score: 46%
Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, 10/13/09
Relevance Score: 46%
Sodium Load Combined with Low Doses of Exogenous Angiotensin II Upregulate Intrarenal Angiotensin II
Kidney and Blood Pressure Research, 10/08/09
Relevance Score: 46%
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Depression, anxiety and obsessive–compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment
Journal of Psychopharmacology, 11/29/09
The Development of Effective Message Content for Suicide Intervention
Crisis: The Journal of Crisis Intervention and Suicide Prevention, 11/29/09
Treatments for common psychiatric conditions among adults during acute, rehabilitation, and reintegration phases
International Review of Psychiatry, 11/29/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline
Journal of Hypertension, 11/29/09
Depression, anxiety and obsessive–compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment
Journal of Psychopharmacology, 11/29/09
Improved statistical analysis of moclobemide dose effects on panic disorder treatment
European Archives of Psychiatry and Clinical Neuroscience, 11/29/09